Quinolone tolerance in Escherichia coli due to defects in the adenosine ribonucleotides de novo biosynthesis pathway

Abstract

Central carbon metabolism is thought to link reactive oxygen species (ROS) with antibiotic-mediated bacterial death. During enrichment screening of Escherichia coli with the first-generation quinolone oxolinic acid, unstable antibiotic-tolerant mutants containing deficiencies in purB were obtained. Examination of a stable deletion mutant of purA, a gene functionally related to purB, revealed reduced lethality of oxolinic acid and ciprofloxacin. This deletion mutation had little effect on the minimal inhibitory concentration (MIC) of quinolones, thereby demonstrating that the observed protection from killing was attributable to antibiotic tolerance. AMP synthesis was blocked by the ΔpurA mutation, and ciprofloxacin tolerance was reversed by exogenous AMP supplementation. Because AMP is a precursor of ATP, interference with ATP synthesis occurs in the ΔpurA mutant. RNA-Seq analysis showed that, prior to antibiotic stress, transcript levels of NADH:quinone oxidoreductase genes were reduced by the purA deficiency, thereby predisposing E. coli to antibiotic tolerance through reduced respiration. During ciprofloxacin exposure, the purA deficiency also suppressed the surge in expression of tricarboxylic acid (TCA) cycle and ATP synthesis genes, as well as the accumulation of intracellular ATP and ROS. Thus, wild-type PurA, and by extension the downstream enzyme PurB, directs AMP toward an antibiotic-mediated, ROS-dependent death pathway. Overall, defects in PurA/PurB-mediated adenosine ribonucleotides de novo biosynthesis reveal a novel quinolone tolerance mechanism that is initiated outside central carbon metabolism; tolerance is likely attributable to a limited supply of AMP, resulting in reduced ATP synthesis and suppression of ROS accumulation.

Keywords

adenosine ribonucleotides de novo biosynthesis / AMP / antibiotic tolerance / PurA/PurB / ROS

References

[1] Wald-Dickler N, Holtom P, Spellberg B. Busting the myth of “static vs cidal”: a systemic literature review. Clin Infect Dis. 2018; 66: 1470–1474.

[2] Pankey GA, Sabath LD. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis. 2004; 38: 864–870.

[3] Ishak A, Mazonakis N, Spernovasilis N, Akinosoglou K, Tsioutis C. Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice. J Antimicrob Chemother. 2025; 80: 1–17.

[4] Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell. 2007; 130: 797–810.

[5] Belenky P, Ye JD, Porter CBM, Cohen NR, Lobritz MA, Ferrante T, et al. Bactericidal antibiotics induce toxic metabolic perturbations that lead to cellular damage. Cell Rep. 2015; 13: 968–980.

[6] Dwyer DJ, Belenky PA, Yang JH, MacDonald IC, Martell JD, Takahashi N, et al. Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci USA. 2014; 111: E2100–E2109.

[7] Lobritz MA, Belenky P, Porter CBM, Gutierrez A, Yang JH, Schwarz EG, et al. Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci USA. 2015; 112: 8173–8180.

[8] Hong Y, Zeng J, Wang X, Drlica K, Zhao X. Post-stress bacterial cell death mediated by reactive oxygen species. Proc Natl Acad Sci USA. 2019; 116: 10064–10071.

[9] Imlay JA. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat Rev Microbiol. 2013; 11: 443–454.

[10] Zeng J, Hong Y, Zhao N, Liu Q, Zhu W, Xiao L, et al. A broadly applicable, stress-mediated bacterial death pathway regulated by the phosphotransferase system (PTS) and the cAMP-Crp cascade. Proc Natl Acad Sci USA. 2022; 119:e2118566119.

[11] Hobbs JK, Boraston AB. (p)ppGpp and the stringent response: an emerging threat to antibiotic therapy. ACS Infect Dis. 2019; 5: 1505–1517.

[12] Irving SE, Choudhury NR, Corrigan RM. The stringent response and physiological roles of (pp)pGpp in bacteria. Nat Rev Microbiol. 2021; 19: 256–271.

[13] Liu JF, Gefen O, Zhang ZY, Liu MM, Bar-Meir M, Balaban NQ. Interaction tolerance detection test for understanding the killing efficacy of directional antibiotic combinations. mBio. 2021; 13:e0000422.

[14] Leshchiner D, Rosconi F, Sundaresh B, Rudmann E, Ramirez LMN, Nishimoto AT, et al. A genome-wide atlas of antibiotic susceptibility targets and pathways to tolerance. Nat Commun. 2022; 13: 3165.

[15] Brauner A, Fridman O, Gefen O, Balaban NQ. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol. 2016; 14: 320–330.

[16] Luan G, Hong Y, Drlica K, Zhao X. Suppression of reactive oxygen species accumulation accounts for paradoxical bacterial survival at high quinolone concentration. Antimicrob Agents Chemother. 2018; 62:e01622-17.

[17] Chen CR, Malik M, Snyder M, Drlica K. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage. J Mol Biol. 1996; 258: 627–637.

[18] Crumplin GC, Smith JT. Nalidixic acid: an antibacterial paradox. Antimicrob Agents Chemother. 1975; 8: 251–261.

[19] Malik M, Hussain S, Drlica K. Effect of anaerobic growth on quinolone lethality with Escherichia coli. Antimicrob Agents Chemother. 2007; 51: 28–34.

[20] Levin-Reisman I, Brauner A, Ronin I, Balaban NQ. Epistasis between antibiotic tolerance, persistence, and resistance mutations. Proc Natl Acad Sci USA. 2019; 116: 14734–14739.

[21] He B, Smith JM, Zalkin H. Escherichia coli purB gene: cloning, nucleotide sequence, and regulation by purR. J Bacteriol. 1992; 174: 130–136.

[22] Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000; 28: 27–30.

[23] Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 2025; 53: D672–D677.

[24] Honzatko RB, Fromm HJ. Structure-function studies of adenylosuccinate synthetase from Escherichia coli. Arch Biochem Biophys. 1999; 370: 1–8.

[25] Unoson C, Wagner EGH. A small SOS-induced toxin is targeted against the inner membrane in Escherichia coli. Mol Microbiol. 2008; 70: 258–270.

[26] Shan Y, Brown Gandt A, Rowe SE, Deisinger JP, Conlon BP, Lewis K. ATP-dependent persister formation in Escherichia coli. mBio. 2017; 8:e02267-16.

[27] Conlon BP, Rowe SE, Gandt AB, Nuxoll AS, Donegan NP, Zalis EA, et al. Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat Microbiol. 2016; 1:16051.

[28] Kwan BW, Valenta JA, Benedik MJ, Wood TK. Arrested protein synthesis increases persister-like cell formation. Antimicrob Agents Chemother. 2013; 57: 1468–1473.

[29] Koebmann BJ, Westerhoff HV, Snoep JL, Nilsson D, Jensen PR. The glycolytic flux in Escherichia coli is controlled by the demand for ATP. J Bacteriol. 2002; 184: 3909–3916.

[30] Brandt R, Keston AS. Synthesis of diacetyldichlorofluorescin: a stable reagent for fluorometric analysis. Anal Biochem. 1965; 11: 6–9.

[31] Wickens HJ, Pinney RJ, Mason DJ, Gant VA. Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure. Antimicrob Agents Chemother. 2000; 44: 682–687.

[32] Yagil E, Beacham IR. Uptake of adenosine 5'-monophosphate by Escherichia coli. J Bacteriol. 1975; 121: 401–405.

[33] van Alphen W, van Seim N, Lugtenberg B. Pores in the outer membrane of Escherichia coli K12: involvement of proteins b and e in the functioning of pores for nucleotides. Mol Gen Genet. 1978; 159: 75–83.

[34] Kano T, Ishikawa K, Furuta K, Kaito C. Knockout of adenylosuccinate synthase purA increases susceptibility to colistin in Escherichia coli. FEMS Microbiol Lett. 2024; 371:fnae007.

[35] Hong Y, Li Q, Gao Q, Xie J, Huang H, Drlica K, et al. Reactive oxygen species play a dominant role in all pathways of rapid quinolone-mediated killing. J Antimicrob Chemother. 2020; 75: 576–585.

[36] Ye Y, Tian Y, Duan M, Zhu W, Wu J, Chen Y, et al. Antibiotic-persistent bacterial cells exhibiting low-level ROS are eradicated by ROS-independent membrane disruption. mBio. 2025; 16:e0119925.

[37] Zheng EJ, Stokes JM, Collins JJ. Eradicating bacterial persisters with combinations of strongly and weakly metabolism-dependent antibiotics. Cell Chem Biol. 2020; 27: 1544–1552.

[38] Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006; 2:2006.0008.

[39] Andersson DI, Nicoloff H, Hjort K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat Rev Microbiol. 2019; 17: 479–496.

[40] Lubrano P, Smollich F, Schramm T, Lorenz E, Alvarado A, Eigenmann SC, et al. Metabolic mutations reduce antibiotic susceptibility of E. coli by pathway-specific bottlenecks. Mol Syst Biol. 2025; 21: 274–293.

[41] Nolan AC, Zeden MS, Kviatkovski I, Campbell C, Urwin L, Corrigan RM, et al. Purine nucleosides interfere with c-di-AMP levels and act as adjuvants to re-sensitize MRSA To β-lactam antibiotics. mBio. 2023; 14:e0247822.

[42] Chen M, Cui R, Hong S, Zhu W, Yang Q, Li J, et al. Broad-spectrum tolerance to disinfectant-mediated bacterial killing due to mutation of the PheS aminoacyl tRNA synthetase. Proc Natl Acad Sci U S A. 2025; 122:e2412871122.

[43] Zeng J, Wu L, Liu Z, Lv Y, Feng J, Wang W, et al. Gain-of-function mutations in acid stress response (evgS) protect Escherichia coli from killing by gallium nitrate, an antimicrobial candidate. Antimicrob Agents Chemother. 2021; 65:e01595–20.

[44] Liu J, Gefen O, Ronin I, Bar-Meir M, Balaban NQ. Effect of tolerance on the evolution of antibiotic resistance under drug combinations. Science. 2020; 367: 200–204.

[45] Zhu W, Chen M, Zhang X, Su J, Zhang X, Nong Y, et al. Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source. mSphere. 2024; 9:e0077224.

[46] Zhu W, Xiao L, Hong S, Wang W, Li W, Luo H, et al. Exogenous glucose interferes with antimicrobial-mediated ROS accumulation and bacterial death. ACS Infect Dis. 2024; 10: 1896–1903.

[47] Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000; 97: 6640–6645.

[48] Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009; 10: 57–63.

[49] Anders S, Pyl PT, Huber W. HTSeq—a python framework to work with high-throughput sequencing data. Bioinformatics. 2015; 31: 166–169.

[50] Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009; 25: 1105–1111.

[51] Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010; 11:R106.

[52] Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq. 2. Genome Biol. 2014; 15: 550.

[53] Wang L, Feng Z, Wang X, Wang X, Zhang X. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics. 2010; 26: 136–138.

[54] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the {L-End} method. Methods. 2001; 25: 402–408.

RIGHTS & PERMISSIONS

2025 The Author(s). mLife published by John Wiley & Sons Australia, Ltd on behalf of Institute of Microbiology, Chinese Academy of Sciences.